ATM and neoplasm: In addition, patients who had ≥3 DDR alterations (including ATM) showed substantially higher tumor mutation burden [TMB] [mean 32.5 mutations/Mb (range 14–72) versus mean 12.4 mutations/Mb (range 0.9–78), p = 0.01].